DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactOrders & Deals

Fine Organic Industries Limited — Disclosure under SEBI Takeover Regulations

NSE 2 hrs ago·8 Sept 2026, 10:40 am

Fine Organic IND

Fine Organic Industries Limited has disclosed that Jayen Ramesh Shah has submitted a report to the stock exchange regarding an acquisition made under a specific exemption from SEBI's Takeover Regulations. This disclosure is made in compliance with Regulation 10(6) of the SEBI (SAST) Regulations, 2011.

This regulatory filing indicates that an investor, Jayen Ramesh Shah, has acquired shares in Fine Organic Industries. The move is significant as it signals a change in shareholding pattern and compliance with corporate governance norms. For investors, this could imply increased institutional interest or a strategic stake in the company.

Investors should monitor the full details of this acquisition in the subsequent filings. It is important to understand the size of the stake and the rationale behind the investment to gauge its potential impact on the company's future strategy and stock performance.